Yenkel Grinberg-Bleyer

6PUBLICATIONS
51CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 02, 2024
NF-κB subunits RelA and c-Rel selectively control CD4+ T cell function in multiple sclerosis and cancer.

Guilhem Lalle, Raphaëlle Lautraite, Khaled Bouherrou

|Mar 19, 2024
Xevinapant Combined with Pembrolizumab in Patients with Advanced, Pretreated, Colorectal and Pancreatic Cancer: Results of the Phase Ib/II CATRIPCA Trial.

Allison Voisin, Catherine Terret, Camille Schiffler

|Nov 06, 2023
A pan-cancer analysis implicates human NKIRAS1 as a tumor-suppressor gene.

Thomas S Postler, Anqi Wang, Francesco G Brundu

|Mar 26, 2021
Tissue-restricted control of established central nervous system autoimmunity by TNF receptor 2-expressing Treg cells.

Emilie Ronin, Charlotte Pouchy, Maryam Khosravi

|Feb 21, 2018
The Alternative NF-κB Pathway in Regulatory T Cell Homeostasis and Suppressive Function.

Yenkel Grinberg-Bleyer, Rachel Caron, John J Seeley

Pageof 1